Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
  • Vanguard’s Mutual Funds Better Than Its ETFs
    Some Vanguard mutual funds carries a modest purchase charge (<0.5%) to gain access to the Investor shares whereas the equivalent ETFs sport lower ERs similar to those of Admiral shares. Also buying/selling these ETFs are commission-free at Vanguard brokerage. I use ETFs and index funds in taxable accounts, and many of the active managed funds in tax deferred accounts.
  • DSENX = Large Value category according to M*
    Thanks --- I know! At Fido the min for is way higher, 100k, I believe, which I would meet, but you still have to pay $50, which totally and immaturely irrationally sticks in my craw. (I could run the numbers.) I just want to be able to bail in a year if need be (the strategy blows up somehow) and go crawling back to the Yackts and PRBLX, with GLRBX for shorter-term.
    I was late to the party also, but learned about it here and dove in, or slowly slid in.
  • DSENX = Large Value category according to M*
    davidrmoran- if you have an IRA with Vanguard or Fido ( maybe others) , you can buy the institutional share class DSEEX for $5000 minimum and save on yearly expenses even after the transaction fee. I can't decide if this enhanced fund should be a core holding. (Not sure about counter party risk issues or how it will react when all sectors are relatively overvalued) I admire your courage. I've enjoyed the ride but was a couple of months late to the launch.
  • For holding "cash" - should I keep loading into RPHYX?
    Well, with RPHYX I'm up some $5600 over my basis. I can't give actual percentage gains because I've added to that account a number of different times, and while I do know the methodology to approximate the percentage gain it's just more trouble than I want to go to, so I just keep the YTD data.
    RSIVX is up 1.3% YTD, not too bad, but it's also a different animal than RPHYX.
    One reason that I like those two is that they're NTF at Schwab, so easy to get into and out of cheaply.
  • For holding "cash" - should I keep loading into RPHYX?
    I have parked cash in RPHYX and RSIVX for about the last 15 months. My basis is actually more than the market values of these funds given the reinvested dividends and paltry increases in NAV. The money seems safe, but I almost feel as though I'm paying someone a parking fee. Like Whakamole, I would never have known about these funds without MFO.
  • For holding "cash" - should I keep loading into RPHYX?
    RPHYX nav dropped .1 % last year, returning 2.6 according to Old_Joe Averaging 3.7 % return over the last 3 years maybe it's time to find a greener pasture? Is the manager running out of places to invest in? Total assets 896,000,000 as of 2/28/15. FWIW ( It seems to me the manage at one time stated the amount of assets he thought the fund could handle). More digging to do.
    Derf
  • European ETFs and CEFs
    IRL. The New Ireland Fund, closed-end.
    http://cef.morningstar.com/quote?pgid=hetopquote&t=IRL
    http://news.morningstar.com/all/ViewNews.aspx?article=/MWR/MWR1176682US_univ.xml
    03/11/15 -- The New Ireland Fund, Inc. (NYSE: IRL) (the "Fund"), a closed-end fund, today announced that it will pay on March 30, 2015, a distribution of US$0.28343 per share to all shareholders of record as of March 23, 2015.
    "Your Fund's distribution policy (the "Distribution Policy") is to provide investors with a stable quarterly distribution out of current income, supplemented by realized capital gains and, to the extent necessary, paid-in capital. As announced in the press release issued on June 15, 2014, the Board has determined that the initial annual rate will be 8% per annum, payable in quarterly installments. .."
    http://news.morningstar.com/all/ViewNews.aspx?article=/MWR/MWR1181158US_univ.xml
    http://news.morningstar.com/all/ViewNews.aspx?article=/MWR/MWR1183434US_univ.xml
    ...I note it is right now trading at a bit better discount than the 3 or 6 month average. I owned it back in the 1990s and made money.
  • German Equities Up 40% Over Past Five Months
    FYI: German stocks have increased 40% over the past five months. Combined with the euro depreciation and lower oil prices it all points to more upside risk to the economic outlook for Europe.
    Regards,
    Ted
    http://www.ritholtz.com/blog/2015/03/german-equities-up-40-over-past-five-months/print/
    DAX Members:
    http://www.bloomberg.com/markets/stocks/movers/dax/
  • Gold ETFs Rally On Fed Move; New Fund Hedges Currency Risk
    FYI: Exchange traded funds holding the beleaguered bullion surged late last week on dovish Fed signals. With an imminent rate hike all but ruled out, the largest ETF tracking the yellow metal, SDPR Gold Shares (ARCA:GLD), popped 2% in Wednesday trade.
    Regards,
    Ted
    http://license.icopyright.net/user/viewFreeUse.act?fuid=MTkxMzU4NDc=
    Enlarged Graphic:
    http://news.investors.com/photopopup.aspx?path=WEBetf032415.png&docId=744750&xmpSource=&width=1000&height=691&caption=&id=744798
  • Bogle’s ETF Critiques Draw Criticism, Ire
    FYI: John “Jack” Bogle, founder and retired CEO of the Vanguard Group, is a staunch detractor of exchange traded funds, but the fund veteran’s feelings may be biased as the ETF industry continues to grow.
    Regards,
    Ted
    http://www.etftrends.com/2015/03/bogles-etf-critiques-draw-criticism-ire/
  • Philadelphia International Fund to liquidate
    @JoJo26
    With a 3,5, and 10-yr performance landing it in the bottom quartile among funds in its category, and with assets of only 17M after over 10 yrs of operation, yes, JoJo, it was not a going concern and hadn't been for quite some time. If not performance then what led to its final demise? Do you have anything whatsoever that suggests otherwise? Do enlighten.
  • Philadelphia International Fund to liquidate
    http://www.sec.gov/Archives/edgar/data/835663/000119312515101422/d890010d497.htm
    d890010d497.htm GLENMEDE FUND INC
    THE GLENMEDE FUND, INC.
    The Philadelphia International Fund
    Supplement dated March 23, 2015 to the Philadelphia International Fund Prospectus
    and Statement of Additional Information, each dated February 28, 2015
    THIS SUPPLEMENT CONTAINS NEW AND ADDITIONAL INFORMATION BEYOND THAT CONTAINED IN THE PROSPECTUS AND STATEMENT OF ADDITIONAL INFORMATION AND SHOULD BE READ IN CONJUNCTION WITH THE PROSPECTUS AND STATEMENT OF ADDITIONAL INFORMATION.
    On March 12, 2015, the Board of Directors of The Glenmede Fund, Inc. (the “Board”) approved a plan of liquidation and termination for the Philadelphia International Fund (the “Fund”). Effective March 24, 2015, the Fund will discontinue accepting orders for the purchase of Fund shares. Any income dividends paid after March 23, 2015 will be paid in cash.
    On or about May 15, 2015 (the “Liquidation Date”), the Fund will be liquidated by distributing to investors holding shares of the Fund on the Liquidation Date their pro rata share of the proceeds in cash and all of the outstanding shares of the Fund will be redeemed. Absent other instructions, the cash proceeds will be distributed by mailing a check to each investor of record at such investor’s address of record. The Fund is in the process of liquidating securities and the Fund may invest all or part of the proceeds from the liquidation of portfolio securities in cash equivalent instruments or hold the proceeds in cash. As disclosed in the Prospectuses, the Fund is permitted to depart from its principal investment strategy by taking temporary defensive positions (up to 100% of its assets) in all types of money market and short-term debt securities. During this time, the Fund may not achieve its investment objective.
    Until the Liquidation Date, investors may redeem their shares in the manner set forth in the Fund’s current Prospectus. The redemption of your shares will generally be considered a taxable event.
    For federal income tax purposes, the tax treatment to investors of the receipt of the liquidating distribution on the Liquidation Date will be the same as would be the tax treatment of a redemption of shares on that date. You may also be subject to state, local or foreign taxes on redemptions or liquidations of Fund shares. The foregoing is only a summary of certain tax considerations under current law, which may change in the future. You should consult your tax adviser for information regarding all tax consequences applicable to your investment in the Fund.
    Please retain this Supplement for future reference.
  • Are Japan Mutual Funds Finally Getting Some Traction?
    An interesting Japan Mutual fund is HJPSX. With a 2.24 % ER and only 15 Million AUM, it holds Micro, Small and Mid cap companies. Over the life of the fund it has performed well against the Japanese Index:
    image
  • The Value Of Skill
    "SPIVA does NOT compare, nor do they advise comparing, the bulk of their funds against a single reference standard. That’s wrongheaded. It is meaningless to contrast the returns of a Small Cap Value fund against the S&P 500 measure. These are obviously horses of a totally different color."
    I always find it interesting by answering one ridiculous statement, with another that contradicts someone's (wrong) findings
    Thus I reply.... 14%x8000 funds=1,120 managers beat S&P in 2014....pretty good I would think
    I like to wait and see if anyone can counter with a more accurate conclusion: a respectable number of active managers do indeed outdistance their benchmarks.
    Which is the correct conclusion: and that is the ONLY conclusion of any managed vs. index funds....e
    enjoy, the next soon to appear article with new misleading figures to promote any conclusion they want
  • The Value Of Skill
    Hi Guys,
    The SPIVA reports have been issued for over a decade now, and the primary conclusions have remained constant during this entire period. Although percentages change depending on the market environment, less than half active mutual fund managers outperform applicable Indices.
    The law of conservation of returns demands this outcome since these active managers are themselves mostly the marketplace. Their cohort underperformance can be roughly estimated by considering the negative impact of costs and fees in the mix.
    SPIVA has done yeomen work in measuring the shortfall distributions in terms of asset classes (large/small, growth/value, US/International, government/corporate bonds, etc.). To fully appreciate and exploit the SPIVA studies, a nuanced review of the many SPIVA tables is required. I recommend that interested MFOers invest that required time.
    SPIVA does NOT compare, nor do they advise comparing, the bulk of their funds against a single reference standard. That’s wrongheaded. It is meaningless to contrast the returns of a Small Cap Value fund against the S&P 500 measure. These are obviously horses of a totally different color.
    The referenced ETF Trends article quoted the 86% record for only one year (2014) and only represented those funds that are assigned to the Large Cap category. The assumption that there are 8,000 funds in that grouping is wrong. In fact, there are typically slightly over 1,000 funds in that classification with a period survival rate that is less than 100%. The 8,000 assumption is grossly in error.
    Therefore, it’s incorrect to calculate that 1,120 active fund managers outdistanced the S&P 500. Also, using a single year’s performance data is similarly wrongheaded; returns are simply too jumpy and non-repeatable year-to-year to reliably use a single year for decision making.
    Even with this correction, a respectable number of active managers do indeed outdistance their benchmarks. But it is a narrow field, and Alpha (excess returns) is a vanishing quantity; a deeper examination of the SPIVA data sets quickly uncovers the disappearing Alpha phenomena. Superstars exist in all professional fields, although the stars’ output does erode with time. So too in the active fund management discipline.
    The erosion of overall Alpha these days is often attributed to the abundant expert, field leveling status of all fund managers. Jesse Livermore, Benjamin Graham, and Warren Buffett battled weaker opponents when establishing their superior records. The persistent perils are becoming a rare find.
    Please do not interpret this post as being generated by a fully committed Indexer. I am not. I am moving in the Indexer direction, but I still maintain over 30% of my portfolio under active fund management. Winners are out there.
    It is a challenge in a multi-dimensional world to identify the potential (never with certainty) winners. A history of positive Alpha is surely a good starting point. Style consistency and tenure are also contributing factors. Also smaller fund size allows the active manager to be more agile. Perhaps the single best discriminator is the overall cost of the fund. The most promising funds offer the lowest ownership costs.
    Several Vanguard studies that have been referenced on MFO earlier demonstrate a situational advantage for active management. Here are repeat Links to that work:
    http://www.vanguard.com/pdf/s356.pdf
    https://pressroom.vanguard.com/content/nonindexed/7.5.2013_The_bumpy_road_to_outperformance.pdf
    Admittedly, Vanguard is constantly grinding its axe, however, please checkout both the Vanguard studies and the SPIVA series. They’ll guide you in identifying solid active fund managers, without any guarantees of course. For example, the SPIVA data clearly show that an investor has a highly likelihood of selecting a superior Alpha fund manager for a Large Cap Value fund then for a Large Cap Growth fund.
    To end on a happy note, I’m sure you all know the story about what they call a mushroom who goes into a bar and orders drinks for the house. A fungi (a fun guy).
    Sorry about that. I suppose this tarnishes my image still further. My stock picking skills are no better than my joke selection skills. That’s yet another reason why I go the mutual fund route.
    Best Wishes.
  • Are Japan Mutual Funds Finally Getting Some Traction?
    Using a simple rule set and 10 mo simple moving average ( monthly basis ) applied to the Nikkei index and Japan Govt bonds, the investment returns over the last 2.5 lost decades of the Japan experience could have been improved and risk mitigated https://docs.google.com/presentation/d/1Sn6BKRCKRU5tensBDFTkJXI3v2wRQ4M1bt8VoIM2Zmc/edit?usp=sharing
  • Are Japan Mutual Funds Finally Getting Some Traction?
    FYI: Japan mutual funds have lagged the S&P 500 since the market bottom in 2011, but they're outperforming this year. Which of these two would have made a smart investment: Putting $10,000 into the average Japan fund on Dec. 31, 1999, or putting that amount into the S&P 500?
    Regards,
    Ted
    http://license.icopyright.net/user/viewFreeUse.act?fuid=MTkxMzE4MzM=
  • Biotech Stocks On Pace To Snap 8-day Win Streak As Warnings Abound
    @Ted
    Agree. A blip right now.
    Memory recall (semi-valid) from last Thursday; SBIO was up about 3.65%, gave most of that back on Friday when other areas were stronger. Down about 1.8% as of this pre-noon write. Note that SBIO are baby bio-techs and likely not reflected within the overall bio area as with your holding of Fido bio fund, which holds more of the established companies.
    Watching; but we do not currently have any holding in SBIO.
    Thinking we'll still make some more $'s in this area, eh?
    Regards,
    Catch